Where does CG BIO Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CG BIO Co., Ltd. ranks #13,912 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CG BIO Co., Ltd. hold?

CG BIO Co., Ltd. holds 21 US utility patents granted between 2015 and 2025, spanning 16 technology areas.

What is CG BIO Co., Ltd.'s Innovation Score?

CG BIO Co., Ltd. has an Innovation Score of 33.7 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CG BIO Co., Ltd.'s patent grant rate increasing or decreasing?

CG BIO Co., Ltd.'s recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for CG BIO Co., Ltd.'s patents?

CG BIO Co., Ltd.'s patents average 8.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CG BIO Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CG BIO Co., Ltd.

Q: What technology areas does CG BIO Co., Ltd. focus on?

CG BIO Co., Ltd.'s top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 14 patents, ranking #200 of 2,589 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CG ranks #13,912 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 16 technology areas.

#13,912
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.7/100): 8.7
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13912 · Foreign Corporation #13,912 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,912/49,997
PHOTO-FINISH Cciip
CPC-FOCUS A61L · 16 areas
INNOV-THIN 33.7/100
CLAIMS-PAR 8.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cciip LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CG’s 33.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (32%) Velocity 3.7 pts (11%) Breadth 14.1 pts (42%) Claim depth 5.2 pts (15%)

Qualcomm Incorporated · highest

85
CG BIO · this assignee

34
3D Lighting… · lowest

7

What this shows CG's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for CG?

Each dot is one of CG’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CG’s own 8.7 claims/patent is at or below the 12.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CG vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CG's grants concentrate

CG BIO Co., Ltd. is a focused PatentsView assignee: 16 CPC subclasses with 66.7% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2016. By volume, CG sits between Cciip LLC and Cinogy GMBH.

CG's three-year grant acceleration

CG BIO Co., Ltd. shows 5 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cciip

21
Celanese Acetate

21
Celeno Communicat…

21
Centaur Technology

21
Changchun Institu…

21
China Oilfield Se…

21
Chirogate Interna…

21
Cinogy

21
CG BIO ◀

21

What this shows CG holds 21 patents at rank #13,906, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CG

By rank, the assignees closest to #13,906 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in CG's primary technology class.

CG's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CG BIO Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	9.5%
2016	1	4.8%
2017	2	9.5%
2018	1	4.8%
2020	2	9.5%
2021	7	33.3%
2022	2	9.5%
2023	1	4.8%
2024	2	9.5%
2025partial year	1	4.8%

Which technologies does CG BIO Co., Ltd. patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 14

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61B - DIAGNOSIS; SURGERY; Identification 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 2

C03C - Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other Materials 2

C08L - Compositions OF Macromolecular Compounds 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

C04B - Lime, MAGNESIA; SLAG; CEMENTS; Compositions Thereof, e.g. Mortars, Concrete OR Like Building MATERIALS; Artificial Stone ; Ceramics ; REFRACTORIES; Treatment OF Natural Stone 1

B28B - Shaping Clay OR Other Ceramic COMPOSITIONS; Shaping SLAG; Shaping Mixtures Containing Cementitious Material, e.g. Plaster 1

C07K - Peptides 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

C03B - Manufacture, Shaping, OR Supplementary Processes 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CG BIO Co., Ltd.'s patent record in context - here's where to go next.

CG BIO Co., Ltd.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 66.7% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #13,912 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CG BIO Co., Ltd. against Cciip LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.